NEW YORK, Jan. 21 - GenoMed on Friday said it has signed a Letter of Intent with the DW Coordinating Center to buy 50 Caucasian samples of "common, serious diseases."
DWCC, a global contract-research group with research ties to Eastern Europe based in Los Altos, Calif., will obtain blood samples from patients with "common diseases" like hypertension, myocardial infarction, stroke, and some cancers.
GenoMed, of St. Louis, Mo., said that over the next 1 to 2 years it "will score millions of genotypes" from these samples and try to identify genomic links that connect particular ethnic groups with a certain disease.
Financial terms of the deal were not disclosed.
"I am confident that the [GenoMed's] relationships with organizations such as DWCC will provide the [it] with the samples that it needs to generate a tremendous amount of disease gene data from a variety of ethnic groups," David Moskowitz, chairman and chief medical officer of GenoMed, said in a statement.
Last November, GenoMed, art the time based in Sarasota, Fla., acquired its St. Louis-based subsidiary, Genomic Medicine. Terms of that deal call for the subsidiary to collect a $2 million to $6 million investment over the next year.